Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Increase (Decrease) in Other Noncurrent Assets

BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Noncurrent Assets

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Noncurrent Assets of -$9.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$7.52M, a 163.30% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$1.48M, a 191.38% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $5.89M, a 85.92% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $19.17M, a 114.02% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2025 was $38.57M, a 47.66% decline from fiscal 2024.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2024 was $73.70M, a 136.60% increase from fiscal 2023.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2023 was $31.15M, a 56.85% increase from fiscal 2022.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2022 was $19.86M, a 201.21% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 3 month as first filedIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 6 month as first filedIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 9 month as first filedIncrease (Decrease) in Other Noncurrent Assets 12 monthIncrease (Decrease) in Other Noncurrent Assets 12 month as first filed
2026-06-30-$7.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$9.01M
10-Q · filed 2026-08-06
-$3.11M
derived: sum of 3 quarters · filed 2026-08-06
$16.06M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$1.48M
10-Q · filed 2026-05-05
$4.41M
derived: sum of 2 quarters · filed 2026-05-05
$23.58M
derived: sum of 3 quarters · filed 2026-05-05
$35.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$5.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.07M
derived: sum of 2 quarters · filed 2026-02-26
$36.95M
derived: sum of 3 quarters · filed 2026-08-06
$38.57M
10-K · filed 2026-02-26
2025-09-30$19.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$31.05M
derived: sum of 2 quarters · filed 2026-08-06
$32.68M
10-Q · filed 2025-10-28
$74.54M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$11.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$13.51M
10-Q · filed 2026-08-06
$55.37M
derived: sum of 3 quarters · filed 2026-08-06
$64.33M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.62M
10-Q · filed 2026-05-05
$43.48M
derived: sum of 2 quarters · filed 2026-05-05
$52.44M
derived: sum of 3 quarters · filed 2026-05-05
$63.19M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$41.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$50.82M
derived: sum of 2 quarters · filed 2026-02-26
$61.57M
derived: sum of 3 quarters · filed 2026-02-26
$73.70M
10-K · filed 2026-02-26
2024-09-30$8.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$19.71M
derived: sum of 2 quarters · filed 2025-10-28
$31.84M
10-Q · filed 2025-10-28
$42.18M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$10.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$22.88M
10-Q · filed 2025-08-05
$33.22M
derived: sum of 3 quarters · filed 2026-02-26
$48.41M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$12.13M
10-Q · filed 2025-05-02
$22.47M
derived: sum of 2 quarters · filed 2026-02-26
$37.66M
derived: sum of 3 quarters · filed 2026-02-26
$42.96M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$10.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.53M
derived: sum of 2 quarters · filed 2026-02-26
$30.83M
derived: sum of 3 quarters · filed 2026-02-26
$31.15M
10-K · filed 2026-02-26
2023-09-30$15.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$20.49M
derived: sum of 2 quarters · filed 2024-10-31
$20.81M
10-Q · filed 2024-10-31
$52.81M
derived: sum of 4 quarters · filed 2025-02-24
2023-06-30$5.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$5.62M
10-Q · filed 2024-08-05
$37.62M
derived: sum of 3 quarters · filed 2025-02-24
$34.62M
derived: sum of 4 quarters · filed 2025-02-24
2023-03-31$323.00K
10-Q · filed 2024-04-26
$32.32M
derived: sum of 2 quarters · filed 2025-02-24
$29.33M
derived: sum of 3 quarters · filed 2025-02-24
$21.62M
derived: sum of 4 quarters · filed 2025-02-24
2022-12-31$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$29.01M
derived: sum of 2 quarters · filed 2025-02-24
$21.30M
derived: sum of 3 quarters · filed 2025-02-24
$19.86M
10-K · filed 2025-02-24
2022-09-30-$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$10.70M
derived: sum of 2 quarters · filed 2023-11-02
-$12.14M
10-Q · filed 2023-11-02
-$5.95M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$7.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$9.15M
10-Q · filed 2023-08-02
-$2.96M
derived: sum of 3 quarters · filed 2024-02-26
-$2.23M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31-$1.44M
10-Q · filed 2023-04-28
$4.75M
derived: sum of 2 quarters · filed 2024-02-26
$5.47M
derived: sum of 3 quarters · filed 2024-02-26
$6.77M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31$6.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$6.91M
derived: sum of 2 quarters · filed 2024-02-26
$8.21M
derived: sum of 3 quarters · filed 2024-02-26
$6.59M
10-K · filed 2024-02-26
2021-09-30$728.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$2.02M
derived: sum of 2 quarters · filed 2022-10-28
$407.00K
10-Q · filed 2022-10-28
$23.87M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$321.00K
10-Q · filed 2022-08-04
$23.14M
derived: sum of 3 quarters · filed 2023-02-27
$23.09M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31-$1.62M
10-Q · filed 2022-04-29
$21.85M
derived: sum of 2 quarters · filed 2023-02-27
$21.79M
derived: sum of 3 quarters · filed 2023-02-27
$26.95M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$23.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$23.41M
derived: sum of 2 quarters · filed 2023-02-27
$28.57M
derived: sum of 3 quarters · filed 2023-02-27
$29.01M
10-K · filed 2023-02-27
$28.65M
10-K · filed 2021-02-26
2020-09-30-$56.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$5.10M
derived: sum of 2 quarters · filed 2021-10-29
$5.54M
10-Q · filed 2021-10-29
$7.33M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$5.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$5.60M
10-Q · filed 2021-07-30
$7.38M
derived: sum of 3 quarters · filed 2022-02-25
$9.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$441.00K
10-Q · filed 2021-04-30
$2.22M
derived: sum of 2 quarters · filed 2022-02-25
$4.74M
derived: sum of 3 quarters · filed 2022-02-25
$11.56M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$4.30M
derived: sum of 2 quarters · filed 2022-02-25
$11.12M
derived: sum of 3 quarters · filed 2022-02-25
$8.89M
10-K · filed 2022-02-25
2019-09-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$9.33M
derived: sum of 2 quarters · filed 2020-11-06
$7.11M
10-Q · filed 2020-11-06
$4.90M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$6.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$4.59M
10-Q · filed 2020-08-05
$2.38M
derived: sum of 3 quarters · filed 2021-02-26
-$920.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$2.22M
10-Q · filed 2020-05-01
-$4.43M
derived: sum of 2 quarters · filed 2021-02-26
-$7.73M
derived: sum of 3 quarters · filed 2021-02-26
-$2.38M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$2.21M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
-$5.51M
derived: sum of 2 quarters · filed 2021-02-26
-$164.00K
derived: sum of 3 quarters · filed 2021-02-26
$935.00K
10-K · filed 2021-02-26
2018-09-30-$3.30M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
$2.05M
derived: sum of 2 quarters · filed 2019-11-04
$3.15M
10-Q/A · filed 2019-11-04
$4.56M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$5.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$6.45M
10-Q · filed 2019-08-02
$7.86M
derived: sum of 3 quarters · filed 2020-02-27
$7.78M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$1.10M
10-Q · filed 2019-04-29
$2.51M
derived: sum of 2 quarters · filed 2020-02-27
$2.43M
derived: sum of 3 quarters · filed 2020-02-27
$3.01M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$1.33M
derived: sum of 2 quarters · filed 2020-02-27
$1.91M
derived: sum of 3 quarters · filed 2020-02-27
$2.44M
10-K · filed 2020-02-27
2017-09-30-$79.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$503.00K
derived: sum of 2 quarters · filed 2018-10-26
$1.03M
10-Q · filed 2018-10-26
$1.01M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$582.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$1.11M
10-Q · filed 2018-08-03
$1.09M
derived: sum of 3 quarters · filed 2019-02-28
$4.65M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$527.00K
10-Q · filed 2018-04-27
$504.00K
derived: sum of 2 quarters · filed 2019-02-28
$4.07M
derived: sum of 3 quarters · filed 2019-02-28
$4.27M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$3.54M
derived: sum of 2 quarters · filed 2019-02-28
$3.75M
derived: sum of 3 quarters · filed 2019-02-28
$4.98M
10-K · filed 2019-02-28
2016-09-30$3.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$3.77M
derived: sum of 2 quarters · filed 2017-10-31
$5.00M
10-Q · filed 2017-10-31
$6.77M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$207.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$1.44M
10-Q · filed 2017-08-02
$3.21M
derived: sum of 3 quarters · filed 2018-02-26
$5.09M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$1.23M
10-Q · filed 2017-05-04
$3.00M
derived: sum of 2 quarters · filed 2018-02-26
$4.89M
derived: sum of 3 quarters · filed 2018-02-26
$4.72M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$3.65M
derived: sum of 2 quarters · filed 2018-02-26
$3.49M
derived: sum of 3 quarters · filed 2018-02-26
$3.16M
10-K · filed 2018-02-26
2015-09-30$1.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$1.72M
derived: sum of 2 quarters · filed 2016-11-03
$1.39M
10-Q · filed 2016-11-03
$1.20M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$167.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$497.00K
10-Q · filed 2016-08-08
-$689.00K
derived: sum of 3 quarters · filed 2017-02-27
$1.38M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$330.00K
10-Q · filed 2016-05-02
-$522.00K
derived: sum of 2 quarters · filed 2017-02-27
$1.55M
derived: sum of 3 quarters · filed 2017-02-27
$5.27M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$1.88M
derived: sum of 2 quarters · filed 2017-02-27
$5.60M
derived: sum of 3 quarters · filed 2017-02-27
$6.52M
10-K · filed 2017-02-27
$6.43M
10-K · filed 2015-03-02
2014-09-30$2.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$5.79M
derived: sum of 2 quarters · filed 2015-11-02
$6.71M
10-Q · filed 2015-11-02
$6.72M
10-Q · filed 2014-10-28
$2.45M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$3.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$4.64M
10-Q · filed 2015-08-05
$4.67M
10-Q · filed 2014-07-31
$380.00K
derived: sum of 3 quarters · filed 2016-02-29
$302.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$920.00K
10-Q · filed 2015-05-05
$955.00K
10-Q · filed 2014-05-02
-$3.34M
derived: sum of 2 quarters · filed 2016-02-29
-$3.42M
derived: sum of 3 quarters · filed 2016-02-29
-$4.05M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$4.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$4.34M
derived: sum of 2 quarters · filed 2016-02-29
-$4.97M
derived: sum of 3 quarters · filed 2016-02-29
-$3.95M
10-K · filed 2016-02-29
-$1.68M
10-K · filed 2014-02-26
2013-09-30-$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
-$709.00K
derived: sum of 2 quarters · filed 2014-10-28
$307.00K
10-Q · filed 2014-10-28
-$2.52M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$631.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$385.00K
10-Q · filed 2014-07-31
-$2.44M
derived: sum of 3 quarters · filed 2015-03-02
-$1.77M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$1.02M
10-Q · filed 2014-05-02
-$1.81M
derived: sum of 2 quarters · filed 2015-03-02
-$1.14M
derived: sum of 3 quarters · filed 2015-03-02
-$948.00K
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$2.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$2.16M
derived: sum of 2 quarters · filed 2015-03-02
-$1.96M
derived: sum of 3 quarters · filed 2015-03-02
$4.08M
10-K · filed 2015-03-02
2012-09-30$670.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$865.00K
derived: sum of 2 quarters · filed 2013-10-28
$6.91M
10-Q · filed 2013-10-28
$7.85M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$195.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
$6.24M
10-Q · filed 2013-07-29
$7.18M
derived: sum of 3 quarters · filed 2014-02-26
$8.82M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$6.04M
10-Q · filed 2013-04-29
$6.99M
derived: sum of 2 quarters · filed 2014-02-26
$8.63M
derived: sum of 3 quarters · filed 2014-02-26
$8.48M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31$947.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$2.59M
derived: sum of 2 quarters · filed 2014-02-26
$2.44M
derived: sum of 3 quarters · filed 2014-02-26
$837.00K
10-K · filed 2014-02-26
2011-09-30$1.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$1.49M
derived: sum of 2 quarters · filed 2012-10-29
-$110.00K
10-Q · filed 2012-10-29
$3.07M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$150.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$1.75M
10-Q · filed 2012-08-02
$1.43M
derived: sum of 3 quarters · filed 2013-02-26
$931.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$1.60M
10-Q · filed 2012-04-30
$1.58M
derived: sum of 2 quarters · filed 2013-02-26
$1.08M
derived: sum of 3 quarters · filed 2013-02-26
2010-12-31$3.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$2.68M
derived: sum of 2 quarters · filed 2013-02-26
$5.33M
10-K · filed 2013-02-26
2010-09-30-$498.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
$2.15M
10-Q · filed 2011-10-31
2010-06-30$2.65M
10-Q · filed 2011-08-01
2009-12-31$1.29M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05